Tag: oncology

May 23, 2018

Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO

The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent

Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018

Medicenna Receives Amendment to Revamp Clinical Trial

The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co....
May 10, 2018

Aptevo Therapeutics Reports First Quarter 2018 Financial Results

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and...
May 10, 2018

BeiGene Reports First Quarter 2018 Financial Results

BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment...
May 9, 2018

Dynavax Reports First Quarter 2018 Financial Results

Dynavax Technologies (NASDAQ:DVAX) today reported financial results for the first quarter ended March 31, 2018. The net loss for the...
May 9, 2018

Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

Kura Oncology (Nasdaq:KURA) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter...
May 9, 2018

OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights

OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced first quarter 2018...